medigraphic.com

2015, Number 1

<< Back Next >>

Rev Esp Cienc Salud 2015; 18 (1)

Obesity and metabolic complications in children school of Delegation Iztapalapa, D.F

Ponce LML, Garrido ML, de la Torre C, Mendoza AJE

Language: Spanish
References: 46
Page: 22-32
PDF size: 615.08 Kb.


ABSTRACT

Have reported the presence of metabolic complications such as insulin resistance and alterations in leptin levels related to obesity accordingly appearance since the childhood and adolescence of a number of chronic diseases and risk factors characteristic of adult. Objective: Analyze the association between obesity and metabolic complications in school children. Material and methods. An observational, crosssectional and analytical study was carried out. The population was 223 children of 10-12 years of a primary school in eastern Mexico City, anthropometric assessment was performed in three categories according to their body mass index (BMI); right below the percentile 85, overweight between percentiles 85-95 and obese value above the 95th percentile, compared with the reference of the National Center for Health Statistics (NCHS), World Health Organization WHO. Central obesity, waist circumference ≥ 90 percentile and the insulin resistance index was determined by HOMA (Homeostasis Model Basement) and leptin levels by RIA techniques. Rating dietary habits and physical activity Results: The results report a positive association between elevated body mass index with insulin resistance and high levels of leptin in children. Children consume energy-dense diets. 57% did not practice any sports being the most sedentary girls. Conclusion: Obese children are at very early ages, signs of metabolic syndrome which may make greater morbidity of chronic diseases such as cardiovascular and metabolic diseases in later stages.


REFERENCES

  1. Hussain SS, Bloom SR. The pharmacological treatment and management of obesity. Postgrad Med 2011; 123: 34-44.

  2. Sánchez–Echenique M. Aspectos epidemiológicos de la obesidad infantil. Rev. Pediatr Aten Primaria Supl 2012; (21): 9-14.

  3. Gutiérrez JP, Rivera – Domaco J, Shamah-Levy T, et al. Encuesta Nacional de Salud y Nutrición 2012. Resultados Nacionales. Cuernavaca, México: Instituto Nacional de Salud Pública, 2012.

  4. Fausto-Guerra J, Valdés-López RM, Alderete-Rodríguez MG, López-Zermeño MC. Antecedentes históricos sociales de la obesidad en México. Invest Salud 2006; 8(2): 91-4.

  5. American Academy of Pediatrics. Committee on Nutrition.Prevention of Pediatric Overweight and Obesity. Pediatrics 2003; 112: 424-430.

  6. González-Castell D, González-Cossío T, Barquera S, Rivera JA. Alimentos industrializados en la dieta de los preescolares mexicanos. Salud Pública de México 2007; 45: 345-356.

  7. Jensen RB, Vielwerth S, Larsen T, Greisen G, Veldhuis J, Juul A. Pituitary-gonadal function in adolescent males born appropriate or small for gestational age with or without intrauterine growth restriction. J Clin Endocrinol Metab 2007; 92: 1353–1357.

  8. Atalah E, Castillo C, Gómez C, Mateluna A, Urteaga C, Castro R, Riumallo J. Malnutrition of the pregnant woman: an overestimated problem. Rev Med Chil 1995; 123: 1531-1538.

  9. Cisneros-Tapia R, Navarrete FA, Gallegos AC, Robles-Sardin AE, Méndez RO, Valencia ME. Insulin sensitivity and associated risk factors in Mexican children and adolescents. Diabetes Care 2005; 28(10): 2546-2547.

  10. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004; 350(23): 2362-2374.

  11. Reaven GM. Role of insulin resistance in human disease. Diabetes care 1988; 37:1595-1607.

  12. Steinberger J. Insulin resistance and cardiovascular risk in the pediatric patient. Progress in Pediatric Cardiology 2001; 12: 169-175.

  13. Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R. Metabolic syndrome. A comprehensive perspective based on interactions between obesity, diabetes and inflammation. Circulation 2005; 111: 1448-1454.

  14. Kissebah A, Krakower G. Regional adiposity and morbidity. Physiol Rev 1994; 74: 761-811.

  15. Arslanian S, Suprasongsin C. Insulin sensitivity, lipids, and body composition in childhood: is syndrome X present? J Clin Endocrinol Metab 1996; 81: 1058-1062.

  16. Caprio S, Bronson M, Sherwin R, Rife S, Tamborlane W. Coexistence of severe insulin resistance and hyperinsulinemia in preadolescent obese children. Diabetologia 1996; 39:1489-1497.

  17. Steinberger J, Moorehead C, Katch V, Rocchini A. Relationship between insulin resistance and abnormal lipid profile in obese adolescents. J Pediatr 1995; 126: 690-695.

  18. Must A, Jacques P, Dallal G, et al. Long term morbidity and mortality of overweight adolescents: a follow-up of the Harvard Growth Study of 1922 to 1935. N Engl J Med. 1992; 327:1350-1355.

  19. Pinhas-Hamiel O, Dolan L, Daniels S, et al. Increased incidence of non-insulin-dependent diabetes mellitus among adolescents. JPediatric 1996; 128: 608-615.

  20. Freedman D, Dietz W, Srinivasan S, et al. The relation of overweight to cardiovascular risk factor among children and adolescents: the Bogalusa Heart Study. Pediatrics 1999; 103: 1175-1182.

  21. Sinaiko AR, Donahue RP, Jacobs DR Jr, Prineas RJ. Relation of weight and rate of increase in weight during childhood and adolescence to body size, blood pressure, fasting insulin, and lipids in young adults: the Minneapolis Childrens Blood Pressure Study. Circulation 1999; 99: 1471-1476.

  22. Mendivil CO, Sierra ID. Acción insulínica y resistencia a la insulina: aspectos moleculares. Revista Facultad de Medicina Universidad Nacional de Colombia. 2005; 53(4)4. Consultado el 28/04/2014.

  23. Sánchez F, García R, Alarcón F, Cruz M. Adipocinas, tejido adiposo y su relación con células del sistema inmune. Gaceta Médica de México, 2005.

  24. Druker R. Regulación del apetito y control hormonal del peso corporal. Fisiología Médica. México, D.F.: Manual Moderno, 2005. ISBN 970-729-069-2.

  25. Hayashino Y, Hennekens CH, Kurth T. Aspirin use and risk of type 2 diabetes in apparently healthy men. Am J Med 2009; 122: 374–379.

  26. Lean M, Han T. Predicting body composition by densitometry from simple anthropometric measurements. Am J Clin Nut 1996; 63: 4-14.

  27. Lohman TG, Roche AF, Martorell R. Anthropometric standardization reference manual. Champaign, IL: Human Kinetics Books; 1988.

  28. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, et al. CDC growth charts: United States. Advance data from vital and health statistics; no. 314. Hyattsville, Maryland: National Center for Health Statistics, 2000.

  29. World Health Organization. Measuring change in nutritional health status. Guidelines for Assessing in nutritional impact of supplementary feeding programmes for vulnerable groups. Geneve: WHO; 1983.

  30. Kuczmarski RJ, Ogden CL, Guo SS, et al. 2000 CDC growth charts for the United States: Methods and development. National Center for Health Statistics. Vital Health Stat 2002; 11(246).

  31. World Health Organization. WHO child growth standards: length/ height-for-age, weight-for-age, weightfor - length, weight-for height and body mass indexfor-age: methods and development. WHO: Geneve, 2006.

  32. Matthews D, Hosker J, Rudenski A, Naylor B, Teacher D, Turner R. Homeostasis model assessment insulin resistance and cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985; 28: 412-419.

  33. Keskin M, Kurtoglu S, Kendirci M, Atabek E, Yazici C. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics 2005; 115: 500-503.

  34. Trayhurn P, Wood IS. Adipokines: inflammation and the pleotropic role of white adipose tissue. Br J Nutr 2014; 92:347-355.

  35. Lin Y, Chen Y, Cline GW, Zhang D, Zong H, Wang Y, et al. The hyperglycemia-induced inflammatory response in adipocytes: the role of reactive oxygen species. J Biol Chem 2005; 280:4617-4626.

  36. Matthaei S, Stumvoll M, Kellerer HU. Pathophysiology and pharmacological treatment of insulin resistance. Endocr Rev 2008: 585-618.

  37. Chiarelli F, Marcovecchio ML. Insulin resistance and obesity in childhood. Eur J Endocrinol 2008: S67-S74.

  38. Caprio S. Insulin resistance in childhood obesity. J Pediatr Endocrinol Metab 2012: 487-492.

  39. Lee M.J, Okumura MM, Davis WH, Herman JG. Prevalence and determinants of insulin resistance among U.S. adolescents: a population-based study. Diabetes Care 2006: 2427-2432.

  40. Bajaj M, Defronzo RA. Metabolic and molecular basis of insulin resistance. J Nucl Cardiol 2003: 311-323.

  41. Pittas AG, Joseph NA, Greenberg AS. Adipocytokines and insulin resistance. J Clin Endocrinol Metab 2004: 447-452.

  42. Lee S, Bacha F, Gungor N, Albanian SA. Racial differences in adiponectin in youth: relationship to visceral fat and insulin sensitivity. Diabetes Care 2006: 51-56.

  43. Matsuzawa Y. White adipose tissue and cardiovascular disease. Best Pract Res Clin Endocrinol Metab 2005: 637-647.

  44. Walberg J, Ward D. Role of physical activity in the etiology and treatment of childhood obesity. Pediatrics 2010; 12: 82-88.

  45. Sharma AJ, Dalenius K, Galuska D, Anandappa M, Borland E, Mackintosh H, Smith R. Div of Nutrition, Physical Activity and Obesity, National Center for Chronic Disease Prevention and Health Promotion, Obesity Prevalence Among Low-In come, Preschool-Aged Children---United States 2009; 58(28): 769-773.

  46. Haffner SM, et al. Leptin concentrations do not predict weight gain. Int J Obes Rel Met Dis 2005; 22: 695-699.




2020     |     www.medigraphic.com